课题基金 / 基金详情

项目摘要

项目成果

Tammy L Kielian的其他基金

相似基金

相关文献

中文摘要
翻译
金黄色葡萄球菌正在成为我们社区面临的最大问题的细菌病原体和 医疗保健设置。金黄色葡萄球菌在宿主体内生存的有效策略是附着在表面和 发育成一个被包裹的细胞群落,称为生物膜。我们最近发现法定人数感应 可以控制浮游或生物膜生活方式之间的平衡,提示这种扩散的调节 机制可能是一种有效的治疗策略。与Kenneth Bayles博士合作( PPG),我们证明了金黄色葡萄球菌分泌核酸酶(Nuc)的缺失导致了 生物膜增厚,抑制二级结构形成,我们证实了最近的一篇报道 金黄色葡萄球菌具有第二种胞外核酸酶活性(Nuc2)。基于这些发现,我们的 中心假设是对胞外核酸酶活性的控制是生物被膜的关键决定因素。 成熟和扩散。为了解决这个问题,在具体目标1中,我们将(I)界定NuC和 Nuc2在生物膜成熟中的作用;(Ii)确定核酸酶活性对生物膜扩散是否重要;以及(Iii) 通过控制核酸酶的暴露来调节生物膜的完整性。我们进一步提出金黄色葡萄球菌核酸酶 是一个重要的毒力因素。为了研究核酸酶在疾病中的作用,我们将与Dr。 Tammy Kielian(项目4负责人)和(I)研究了核酸酶活性在中性粒细胞逃避中的作用 细胞外陷阱(Net);(Ii)确定核酸酶在小鼠浮游动物模型中的意义 生物膜感染;以及(Iii)比较宿主对浮游生物和生物膜中核酸酶的炎症反应 感染。最后,我们推测核酸酶活性的小分子诱导剂可能作为ANFI-生物膜。 治疗学。为此,在具体目标3中,我们将使用新技术来生成环肽 适用于高通量筛选方法的金黄色葡萄球菌文库。更具体地说,我们将(I) 筛选通过流式细胞仪诱导核酸酶表达的环肽;(Ii)进行分子和 识别多肽目标的生物化学研究;(Iii)将最佳候选者表征为 生物被膜感染模型;以及(Iv)将结果与核酸酶活性增加的转座子突变体进行比较。 总体而言,该项目的目标是了解这些金黄色葡萄球菌生物膜结构是如何形成和 分解,细胞外DNA在这一过程中的贡献,以及与疾病的相关性。 相关性(请参阅说明):
英文摘要
Staphylococcus aureus is emerging as the most problemafic bacterial pathogen facing our community and healthcare settings. An effective strategy for S. aureus to survive in the host is to attach to a surface and develop into an encased community of cells called a biofilm. We recenfiy discovered that quorum-sensing can control the balance between a planktonic or biofilm lifestyle, suggesfing that modulafion of this dispersal mechanism could be an effective therapeutic strategy. In collaboration with Dr. Kenneth Bayles (the PI of this PPG), we demonstrated that a deletion of the S. aureus secreted nuclease (Nuc) caused an overall thickening of the biofilm and inhibited secondary structure formation, and we have confirmed a recent report that S. aureus possesses a second extracellular nuclease activity (Nuc2). Based on these findings, our central hypothesis is that control over extracellular nuclease activity is a critical determinant of biofilm maturafion and dispersal. To address this quesfion, in Specific Aim 1 we will (i) define the role of Nuc and Nuc2 in biofilm maturation; (ii) determine whether nuclease activity is important for biofilm dispersal; and (iii) modulate biofilm integrity with controlled exposure to nuclease. We further propose that S. aureus nuclease is an important virulence factor. To investigate the nuclease funcfion in disease, we will work with Dr. Tammy Kielian (Project 4 leader) and (i) examine the role of nuclease acfivity in evasion of neutrophil extracellular traps (NETs); (ii) define the significance of nuclease in mouse models of planktonic versus biofilm infecfion; and (iii) compare the host inflammatory response to nuclease in planktonic versus biofilm infection. Finally, we speculate that small-molecule inducers of nuclease activity could serve as anfi-biofilm therapeufics. Towards this end, in Specific Aim 3, we will employ new technology to generate cyclic peptide libraries in S. aureus that are amenable to high-throughput screening methods. More specifically, we will (i) screen for cyclic pepfides that induce nuclease expression through FACS; (ii) perform molecular and biochemical studies to identify pepfide targets; (iii) characterize the best candidates as dispersal agents in a biofilm infection model; and (iv) compare results to transposon mutants with increased nuclease activity. Overall, the goal of this Project is to understand how these S. aureus biofilm structures form and disassemble, the contribufion of extracellular DNA to this process, and the relevance in disease. RELEVANCE (See instructions):
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulating granulocytic myeloid-derived suppressor cell (G-MDSC) metabolic activity to promote Staphylococcus aureus biofilm clearance
T cell-innate immune crosstalk regulates Staphylococcus aureus craniotomy infection
Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection
Immune mechanisms that promote S. aureus persistence during craniotomy-associated biofilm infection
海外基金